Chetan Bangera – Cipla
View Detailed Executive Profile →Professional Overview
- Chetan Bangera founded Gattz HSL in August 2019, establishing a new venture focused on innovative solutions.
- Prior to Gattz HSL, Chetan served as the Regional Head for Latin America at Cipla from October 2018 to July 2019, overseeing regional operations and market strategies.
- Between January 2017 and September 2018, Chetan was the Regional Head for China and Asia Pacific B2B at Cipla, contributing to the company's expansion into new markets.
- In June 2015, Chetan began a role at Mylan as Sr. General Manager & Area Director for Asia Pacific, where strategic decisions likely influenced the company's direction in the region.
- Chetan held the position of Director for Operational Execution at MSD from April 2012 until April 2015, focusing on emerging markets and enhancing operational efficiencies.
- At Dr. Reddy's Laboratories, Chetan was an Associate Director and Head of Strategic Marketing for Global Generics in India from January 2010 to April 2012, shaping marketing strategies and leading teams.
- Various roles at Dr. Reddy's Laboratories from 2005 to 2010 included leadership in sales, marketing, and administration, significantly contributing to the company's growth in oncology.
- Chetan's early career included positions at AstraZeneca and Sun Pharmaceutical Industries Ltd, where essential marketing and product management skills were developed, instrumental for later roles.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Cipla | Regional Head - Latin America | Oct 2018 – Jul 2019 |
| Mylan | Sr. General Manager & Area Director: Asia Pacific - 1 | Jun 2015 – Jan 2017 |
| Cipla | Regional Head - China and Asia Pacific B2B | Jan 2017 – Sep 2018 |
| Dr. Reddy's Laboratories | Associate Director and Head - Strategic Marketing (Global Generics - India) | Jan 2010 – Apr 2012 |
| Dr. Reddy's Laboratories | Associate Director and Head - Administration (Operations); (Brazil) | Jan 2008 – Jan 2010 |
| Dr. Reddy's Laboratories | Head - Sales & Marketing, Oncology (Brazil) | Jan 2007 – Jan 2008 |
| Dr. Reddy's Laboratories | Sr. Manager - Strategic Marketing (China) | Jan 2005 – Jan 2007 |
| Dr. Reddy's Laboratories | National Business Manager - Sales and Marketing, Oncology (India) | Jan 2004 – Jan 2005 |
| Dr. Reddy's Laboratories | Marketing Manager - Oncology (India) | Jan 2003 – Jan 2004 |
| AstraZeneca | Marketing Manager - Oncology (India) | Jan 2002 – Jan 2003 |
| Sun Pharmaceutical Industries Ltd | Product Manager | Jan 1998 – Jan 2002 |
| Schering-Plough Pharmaceuticals | Area Business Executive | Jan 1995 – Jan 1998 |
| Schering-Plough Pharmaceuticals | Professional Service Representative | Jan 1993 – Jan 1995 |
| MSD | Director - Operational Execution; Emerging Markets (for MSD-SUN JV) | Apr 2012 – Apr 2015 |
| Gattz HSL | Founder | Aug 2019 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Cipla corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Chetan Bangera's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Cipla's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)